AHA: Obesity-Linked Ischemic Heart Disease Mortality Increasing in U.S.

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 13, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Nov. 13, 2024 -- In the United States, obesity-related ischemic heart disease (IHD) mortality is increasing, with the highest rates seen among men, Blacks, and those in the Midwest, according to a study presented at the American Heart Association Scientific Sessions 2024, held from Nov. 16 to 18 in Chicago.

Using data from the U.S. Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research database, Aleenah Mohsin, M.D., M.B.B.S., from Brown University in Providence, Rhode Island, and colleagues examined trends in obesity-related IHD mortality in the United States from 1999 to 2020, paying particular attention to racial, local, regional, age, and gender differences in these trends.

The researchers identified 226,267 deaths due to obesity-related IHD from 1999 to 2020. During the study period, there was a uniform increase in the age-adjusted mortality rate (AAMR), with an average annual percentage change (AAPC) of 5.03. Men had a higher AAMR than women overall (3.9 versus 2.2). Men also had a more prominent incline in mortality rates (AAPC, 5.11), especially those men aged 55 to 64 years (AAMR, 8.5). The highest age-adjusted mortality was seen among Black patients (3.93 deaths per 100,000 people). Significant geographical differences were noted, with the highest mortality seen in Midwestern states (AAMR, 3.3); specifically, Vermont had the highest and Alabama the lowest AAMR (10.4 and 1.5, respectively). Compared with metropolitan areas, nonmetropolitan areas had higher AAMRs (4.0 versus 2.9).

"Our findings underscore the need to explore the underlying causes of these disparities, such as differences in health care access, socioeconomic factors and regional health policies," Mohsin said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords